Instem PLC (LON:INS)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as low as $404.00. Instem shares last traded at $396.00, with a volume of 492 shares traded.
The stock has a market cap of $63.97 million and a P/E ratio of 45.52. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.11 and a quick ratio of 1.00. The business has a 50 day moving average price of GBX 373.88.
In other Instem news, insider Michael McGoun sold 6,786 shares of the company’s stock in a transaction dated Wednesday, May 29th. The stock was sold at an average price of GBX 340 ($4.44), for a total transaction of £23,072.40 ($30,148.18).
About Instem (LON:INS)
Instem plc provides information technology solutions to the life science market worldwide. The company offers solutions for data collection, management, and analysis to meet the needs of life science and healthcare organizations for data-driven decision making. Its solutions include Provantis, an integrated Windows-based system for organizations and universities that are engaged in non-clinical evaluation studies; submit platform that provides a suite of integrated tools and services for the creation and management of SEND datasets and associated documents for contract research organizations and sponsors; ALPHADAS, an eSource EDC system for early phase clinical trials; Animal Care Information System, an animal management software solution; Logbook, a repository for information; and Toxicology Resource Planning, a toxicology solution for pharmaceutical, chemical, and contract research laboratory corporations.
Further Reading: Earnings Per Share
Receive News & Ratings for Instem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Instem and related companies with MarketBeat.com's FREE daily email newsletter.